Thoughts on creativity, Pharma and whatnot
Over the last few months we've heard a lot of exciting news about agencies and clients reinventing the 'advertising agency model'. Not the whole agency, obviously, just the interesting part with all the tattooed beardy men and purple haired women. Because you see, Creative departments simply weren't working before. What? you hadn't noticed? That's why... Continue Reading →
In research it's always nice to hear that respondents 'liked' your idea. But so what? The problem is people like a lot of things, pictures of puppies, pretty colours, the way the model looks strong, the happy setting of a family on holiday because it reminds them of that time in Corfu. It doesn't really... Continue Reading →
One of the curious things about Pharmaland is, given the greatest drug ever, say the cure for all Cancer, the cure for Alzheimer's or Diabetes, you could literally run a picture of a pig in a pair of knickers and as long as the headline still said "IT CURES ALL CANCER" nobody would care, the... Continue Reading →
My chum and MD Phil Bartlett recently sent an all staffer round that I thought would be great as a guest spot on this humble blog. Plus, it's been a busy couple of weeks and this plugs a gap nicely. Enjoy! As a “non-creative”, how do I approach the gnarly subject of judging someone else’s... Continue Reading →
I admit it, I have a big problem with Pharma creative research. Or rather... I have a big problem with the creative research that I have been involved in thus far, within Pharmaland. Maybe there are some forward thinking outfits out there that are breaking all the rules, I dunno. But assuming I can wallow... Continue Reading →
I was recently sat in an awards jury, as you do, when a 'medical person' insisted that in one category all you really had to do, to launch a new drug, was to announce its arrival. Drug X does Y. No selling or creativity was required. It was a curious, if not uncommon occurrence, to... Continue Reading →
This has stood out from my first day in pharmaland as a big difference between health and consumer. The worry that the marketing of a new drug might imply the HCP has been doing it wrong up to now and the (ad) concept might offend their sense of professional pride. And why do we worry... Continue Reading →
ollycaporn's blag 